NCT05159752 2023-06-18
A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum (XP)
Clinuvel Pharmaceuticals Limited
Phase 2 Unknown
Clinuvel Pharmaceuticals Limited
Direction Centrale du Service de Santé des Armées
Henry Ford Health System